Vital Signs Research Group Conducts FDA-Compliant Glucometer Testing and Validation Studies in San Francisco
Vital Signs Research Group, located in San Francisco, CA, is actively conducting glucometer testing and validation studies to meet stringent FDA accuracy requirements for blood glucose monitoring devices. These studies are crucial for manufacturers seeking FDA 510(k) clearance for their products, which range from traditional fingerstick glucometers to continuous glucose monitoring (CGM) adjacent devices. The research group designs clinical studies tailored to the specific intended use, target population, and regulatory pathway of each device. Their testing protocols align with FDA guidance on blood glucose monitors and applicable ISO 15197 accuracy standards for non-significant risk devices. All studies are reviewed and approved by an external Institutional Review Board (IRB), Advarra, and adhere to ISO 14155, FDA 21 CFR 50, and FDA 21 CFR 812 regulations. The company recruits study participants from a pre-screened database, ensuring a diverse range of glucose levels and demographics to meet FDA requiremen...
